Treating Marijuana and Synthetic Cannabinoid Toxicoses

Original Presentation Date:
11/21/2016

Free (Non-CE / CE Eligible)
Free for Premium Membership subscribers

Melissa Holahan, DVM, DACVECC discusses cannabinoid exposure and toxicity. Discussion includes the differences in presenting clinical signs associated with marijuana toxicity vs. synthetic cannabinoid exposure, as well as treatment considerations. Access an evaluation form / Earn CE credit: http://vetvine.com/article/218/critical-care-ebu-survey

You might also like

Protein Losing Enteropathy - Therapeutic Management And The Crucial Role Of Nutrition

09/17/2024

adbsad.  lorem su.  i donnot lost uptown. Said he!  THen I said. this! why i don't...

Read More

Practical Neurology Pearls: Intervertebral Disc Disease and Epidural Hemorrhage (it's evil friend)

07/24/2023

To be available for viewing On Demand. Intervertebral disc disease is one of the most common dise...

Read More

Advanced Therapies for Osteoarthritis - Photobiomodulation and Injectable Therapies

06/27/2023

Presented by Dr. Matthew Brunke Access an evaluation / Earn CE credit by viewing this in its en...

Read More

Practical Neurology Pearls: Pug Dog Encephalitis - Understanding Necrotizing Meningoencephalitis

06/21/2023

In this segment Dr. Rebecca Windsor discusses our current understanding of necrotizing meningoence...

Read More

Treating chronic pain in pets is not always straightforward

06/05/2023

Pain is truly an individual experience for both humans and our animal companions. Every patient's...

Read More

Managing Chronic Pain in Dogs and Cats - Innovative Pharmaceutical Approaches

06/05/2023

The pain of arthritis (osteoarthritis or OA) adversely impacts the lives of dogs and cats as well as...

Read More